Articles by tag: pharmaceutical-industry

Johnson & Johnson spin-off of Kenvue: spin-off and deal

Analysis of the Kenvue spin-off from Johnson & Johnson: declining revenue, Tylenol risks, $48.7 billion deal with Kimberly-Clark. Find out who benefits. Read details.

Big Pharma Mergers: $84 Billion in Deals in a Quarter

The $300 Billion Patent Cliff Drove Big Pharma to Spend $84 Billion on Biotech Deals in Q1. Find Out Which Companies Are Buying and Why.